img

Global Branded Generics Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Branded Generics Market Insights, Forecast to 2034

This report mainly focuses on branded generics market. Branded generics are generic drugs that have been given a proprietary market name. They may be marketed similarly to how branded drugs are. Branded generic drugs attach proprietary names to generic drug molecules. 
Global Branded Generics market is expected to reach to US$ 326 million in 2024, with a positive growth of %, compared with US$ 312 million in 2022. Backed with the increasing demand from downstream industries, Branded Generics industry is evaluated to reach US$ 523.1 million in 2029. The CAGR will be 8.2% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Branded Generics market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Branded Generics market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Mylan NV
Novartis AG
Eva Pharmaceutical Industries
Pfizer
Sun Pharmaceutical Industries
Aspen Pharmacare Holding
Abbott Laboratories
Bausch Health
Segment by Type
Oral
Parenteral
Topical
Other

Segment by Application


Oncology
Cardiovascular Diseases
Diabetes
Neurology
Gastrointestinal Diseases
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Branded Generics plant distribution, commercial date of Branded Generics, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Branded Generics introduction, etc. Branded Generics Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Branded Generics
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Branded Generics Product Introduction
1.2 Market by Type
1.2.1 Global Branded Generics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Oral
1.2.3 Parenteral
1.2.4 Topical
1.2.5 Other
1.3 Market by Application
1.3.1 Global Branded Generics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Oncology
1.3.3 Cardiovascular Diseases
1.3.4 Diabetes
1.3.5 Neurology
1.3.6 Gastrointestinal Diseases
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Branded Generics Sales Estimates and Forecasts 2018-2029
2.2 Global Branded Generics Revenue by Region
2.2.1 Global Branded Generics Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Branded Generics Revenue by Region (2018-2024)
2.2.3 Global Branded Generics Revenue by Region (2024-2029)
2.2.4 Global Branded Generics Revenue Market Share by Region (2018-2029)
2.3 Global Branded Generics Sales Estimates and Forecasts 2018-2029
2.4 Global Branded Generics Sales by Region
2.4.1 Global Branded Generics Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Branded Generics Sales by Region (2018-2024)
2.4.3 Global Branded Generics Sales by Region (2024-2029)
2.4.4 Global Branded Generics Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Branded Generics Sales by Manufacturers
3.1.1 Global Branded Generics Sales by Manufacturers (2018-2024)
3.1.2 Global Branded Generics Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Branded Generics in 2022
3.2 Global Branded Generics Revenue by Manufacturers
3.2.1 Global Branded Generics Revenue by Manufacturers (2018-2024)
3.2.2 Global Branded Generics Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Branded Generics Revenue in 2022
3.3 Global Key Players of Branded Generics, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Branded Generics Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Branded Generics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Branded Generics, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Branded Generics, Product Offered and Application
3.8 Global Key Manufacturers of Branded Generics, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Branded Generics Sales by Type
4.1.1 Global Branded Generics Historical Sales by Type (2018-2024)
4.1.2 Global Branded Generics Forecasted Sales by Type (2024-2029)
4.1.3 Global Branded Generics Sales Market Share by Type (2018-2029)
4.2 Global Branded Generics Revenue by Type
4.2.1 Global Branded Generics Historical Revenue by Type (2018-2024)
4.2.2 Global Branded Generics Forecasted Revenue by Type (2024-2029)
4.2.3 Global Branded Generics Revenue Market Share by Type (2018-2029)
4.3 Global Branded Generics Price by Type
4.3.1 Global Branded Generics Price by Type (2018-2024)
4.3.2 Global Branded Generics Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Branded Generics Sales by Application
5.1.1 Global Branded Generics Historical Sales by Application (2018-2024)
5.1.2 Global Branded Generics Forecasted Sales by Application (2024-2029)
5.1.3 Global Branded Generics Sales Market Share by Application (2018-2029)
5.2 Global Branded Generics Revenue by Application
5.2.1 Global Branded Generics Historical Revenue by Application (2018-2024)
5.2.2 Global Branded Generics Forecasted Revenue by Application (2024-2029)
5.2.3 Global Branded Generics Revenue Market Share by Application (2018-2029)
5.3 Global Branded Generics Price by Application
5.3.1 Global Branded Generics Price by Application (2018-2024)
5.3.2 Global Branded Generics Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Branded Generics Market Size by Type
6.1.1 US & Canada Branded Generics Sales by Type (2018-2029)
6.1.2 US & Canada Branded Generics Revenue by Type (2018-2029)
6.2 US & Canada Branded Generics Market Size by Application
6.2.1 US & Canada Branded Generics Sales by Application (2018-2029)
6.2.2 US & Canada Branded Generics Revenue by Application (2018-2029)
6.3 US & Canada Branded Generics Market Size by Country
6.3.1 US & Canada Branded Generics Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Branded Generics Sales by Country (2018-2029)
6.3.3 US & Canada Branded Generics Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Branded Generics Market Size by Type
7.1.1 Europe Branded Generics Sales by Type (2018-2029)
7.1.2 Europe Branded Generics Revenue by Type (2018-2029)
7.2 Europe Branded Generics Market Size by Application
7.2.1 Europe Branded Generics Sales by Application (2018-2029)
7.2.2 Europe Branded Generics Revenue by Application (2018-2029)
7.3 Europe Branded Generics Market Size by Country
7.3.1 Europe Branded Generics Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Branded Generics Sales by Country (2018-2029)
7.3.3 Europe Branded Generics Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Branded Generics Market Size
8.1.1 China Branded Generics Sales (2018-2029)
8.1.2 China Branded Generics Revenue (2018-2029)
8.2 China Branded Generics Market Size by Application
8.2.1 China Branded Generics Sales by Application (2018-2029)
8.2.2 China Branded Generics Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Branded Generics Market Size by Type
9.1.1 Asia Branded Generics Sales by Type (2018-2029)
9.1.2 Asia Branded Generics Revenue by Type (2018-2029)
9.2 Asia Branded Generics Market Size by Application
9.2.1 Asia Branded Generics Sales by Application (2018-2029)
9.2.2 Asia Branded Generics Revenue by Application (2018-2029)
9.3 Asia Branded Generics Sales by Region
9.3.1 Asia Branded Generics Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Branded Generics Revenue by Region (2018-2029)
9.3.3 Asia Branded Generics Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Branded Generics Market Size by Type
10.1.1 Middle East, Africa and Latin America Branded Generics Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Branded Generics Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Branded Generics Market Size by Application
10.2.1 Middle East, Africa and Latin America Branded Generics Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Branded Generics Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Branded Generics Sales by Country
10.3.1 Middle East, Africa and Latin America Branded Generics Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Branded Generics Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Branded Generics Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Mylan NV
11.1.1 Mylan NV Company Information
11.1.2 Mylan NV Overview
11.1.3 Mylan NV Branded Generics Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Mylan NV Branded Generics Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Mylan NV Recent Developments
11.2 Novartis AG
11.2.1 Novartis AG Company Information
11.2.2 Novartis AG Overview
11.2.3 Novartis AG Branded Generics Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Novartis AG Branded Generics Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Novartis AG Recent Developments
11.3 Eva Pharmaceutical Industries
11.3.1 Eva Pharmaceutical Industries Company Information
11.3.2 Eva Pharmaceutical Industries Overview
11.3.3 Eva Pharmaceutical Industries Branded Generics Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Eva Pharmaceutical Industries Branded Generics Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Eva Pharmaceutical Industries Recent Developments
11.4 Pfizer
11.4.1 Pfizer Company Information
11.4.2 Pfizer Overview
11.4.3 Pfizer Branded Generics Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Pfizer Branded Generics Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Pfizer Recent Developments
11.5 Sun Pharmaceutical Industries
11.5.1 Sun Pharmaceutical Industries Company Information
11.5.2 Sun Pharmaceutical Industries Overview
11.5.3 Sun Pharmaceutical Industries Branded Generics Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Sun Pharmaceutical Industries Branded Generics Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Sun Pharmaceutical Industries Recent Developments
11.6 Aspen Pharmacare Holding
11.6.1 Aspen Pharmacare Holding Company Information
11.6.2 Aspen Pharmacare Holding Overview
11.6.3 Aspen Pharmacare Holding Branded Generics Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Aspen Pharmacare Holding Branded Generics Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Aspen Pharmacare Holding Recent Developments
11.7 Abbott Laboratories
11.7.1 Abbott Laboratories Company Information
11.7.2 Abbott Laboratories Overview
11.7.3 Abbott Laboratories Branded Generics Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Abbott Laboratories Branded Generics Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Abbott Laboratories Recent Developments
11.8 Bausch Health
11.8.1 Bausch Health Company Information
11.8.2 Bausch Health Overview
11.8.3 Bausch Health Branded Generics Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Bausch Health Branded Generics Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Bausch Health Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Branded Generics Industry Chain Analysis
12.2 Branded Generics Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Branded Generics Production Mode & Process
12.4 Branded Generics Sales and Marketing
12.4.1 Branded Generics Sales Channels
12.4.2 Branded Generics Distributors
12.5 Branded Generics Customers
13 Market Dynamics
13.1 Branded Generics Industry Trends
13.2 Branded Generics Market Drivers
13.3 Branded Generics Market Challenges
13.4 Branded Generics Market Restraints
14 Key Findings in The Global Branded Generics Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Branded Generics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Oral
Table 3. Major Manufacturers of Parenteral
Table 4. Major Manufacturers of Topical
Table 5. Major Manufacturers of Other
Table 6. Global Branded Generics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Branded Generics Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Branded Generics Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global Branded Generics Revenue by Region (2024-2029) & (US$ Million)
Table 10. Global Branded Generics Revenue Market Share by Region (2018-2024)
Table 11. Global Branded Generics Revenue Market Share by Region (2024-2029)
Table 12. Global Branded Generics Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 13. Global Branded Generics Sales by Region (2018-2024) & (K MT)
Table 14. Global Branded Generics Sales by Region (2024-2029) & (K MT)
Table 15. Global Branded Generics Sales Market Share by Region (2018-2024)
Table 16. Global Branded Generics Sales Market Share by Region (2024-2029)
Table 17. Global Branded Generics Sales by Manufacturers (2018-2024) & (K MT)
Table 18. Global Branded Generics Sales Share by Manufacturers (2018-2024)
Table 19. Global Branded Generics Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global Branded Generics Revenue Share by Manufacturers (2018-2024)
Table 21. Global Key Players of Branded Generics, Industry Ranking, 2021 VS 2022 VS 2024
Table 22. Branded Generics Price by Manufacturers 2018-2024 (USD/MT)
Table 23. Global Branded Generics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Branded Generics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Branded Generics as of 2022)
Table 25. Global Key Manufacturers of Branded Generics, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Branded Generics, Product Offered and Application
Table 27. Global Key Manufacturers of Branded Generics, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Branded Generics Sales by Type (2018-2024) & (K MT)
Table 30. Global Branded Generics Sales by Type (2024-2029) & (K MT)
Table 31. Global Branded Generics Sales Share by Type (2018-2024)
Table 32. Global Branded Generics Sales Share by Type (2024-2029)
Table 33. Global Branded Generics Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global Branded Generics Revenue by Type (2024-2029) & (US$ Million)
Table 35. Global Branded Generics Revenue Share by Type (2018-2024)
Table 36. Global Branded Generics Revenue Share by Type (2024-2029)
Table 37. Branded Generics Price by Type (2018-2024) & (USD/MT)
Table 38. Global Branded Generics Price Forecast by Type (2024-2029) & (USD/MT)
Table 39. Global Branded Generics Sales by Application (2018-2024) & (K MT)
Table 40. Global Branded Generics Sales by Application (2024-2029) & (K MT)
Table 41. Global Branded Generics Sales Share by Application (2018-2024)
Table 42. Global Branded Generics Sales Share by Application (2024-2029)
Table 43. Global Branded Generics Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global Branded Generics Revenue by Application (2024-2029) & (US$ Million)
Table 45. Global Branded Generics Revenue Share by Application (2018-2024)
Table 46. Global Branded Generics Revenue Share by Application (2024-2029)
Table 47. Branded Generics Price by Application (2018-2024) & (USD/MT)
Table 48. Global Branded Generics Price Forecast by Application (2024-2029) & (USD/MT)
Table 49. US & Canada Branded Generics Sales by Type (2018-2024) & (K MT)
Table 50. US & Canada Branded Generics Sales by Type (2024-2029) & (K MT)
Table 51. US & Canada Branded Generics Revenue by Type (2018-2024) & (US$ Million)
Table 52. US & Canada Branded Generics Revenue by Type (2024-2029) & (US$ Million)
Table 53. US & Canada Branded Generics Sales by Application (2018-2024) & (K MT)
Table 54. US & Canada Branded Generics Sales by Application (2024-2029) & (K MT)
Table 55. US & Canada Branded Generics Revenue by Application (2018-2024) & (US$ Million)
Table 56. US & Canada Branded Generics Revenue by Application (2024-2029) & (US$ Million)
Table 57. US & Canada Branded Generics Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 58. US & Canada Branded Generics Revenue by Country (2018-2024) & (US$ Million)
Table 59. US & Canada Branded Generics Revenue by Country (2024-2029) & (US$ Million)
Table 60. US & Canada Branded Generics Sales by Country (2018-2024) & (K MT)
Table 61. US & Canada Branded Generics Sales by Country (2024-2029) & (K MT)
Table 62. Europe Branded Generics Sales by Type (2018-2024) & (K MT)
Table 63. Europe Branded Generics Sales by Type (2024-2029) & (K MT)
Table 64. Europe Branded Generics Revenue by Type (2018-2024) & (US$ Million)
Table 65. Europe Branded Generics Revenue by Type (2024-2029) & (US$ Million)
Table 66. Europe Branded Generics Sales by Application (2018-2024) & (K MT)
Table 67. Europe Branded Generics Sales by Application (2024-2029) & (K MT)
Table 68. Europe Branded Generics Revenue by Application (2018-2024) & (US$ Million)
Table 69. Europe Branded Generics Revenue by Application (2024-2029) & (US$ Million)
Table 70. Europe Branded Generics Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Europe Branded Generics Revenue by Country (2018-2024) & (US$ Million)
Table 72. Europe Branded Generics Revenue by Country (2024-2029) & (US$ Million)
Table 73. Europe Branded Generics Sales by Country (2018-2024) & (K MT)
Table 74. Europe Branded Generics Sales by Country (2024-2029) & (K MT)
Table 75. China Branded Generics Sales by Type (2018-2024) & (K MT)
Table 76. China Branded Generics Sales by Type (2024-2029) & (K MT)
Table 77. China Branded Generics Revenue by Type (2018-2024) & (US$ Million)
Table 78. China Branded Generics Revenue by Type (2024-2029) & (US$ Million)
Table 79. China Branded Generics Sales by Application (2018-2024) & (K MT)
Table 80. China Branded Generics Sales by Application (2024-2029) & (K MT)
Table 81. China Branded Generics Revenue by Application (2018-2024) & (US$ Million)
Table 82. China Branded Generics Revenue by Application (2024-2029) & (US$ Million)
Table 83. Asia Branded Generics Sales by Type (2018-2024) & (K MT)
Table 84. Asia Branded Generics Sales by Type (2024-2029) & (K MT)
Table 85. Asia Branded Generics Revenue by Type (2018-2024) & (US$ Million)
Table 86. Asia Branded Generics Revenue by Type (2024-2029) & (US$ Million)
Table 87. Asia Branded Generics Sales by Application (2018-2024) & (K MT)
Table 88. Asia Branded Generics Sales by Application (2024-2029) & (K MT)
Table 89. Asia Branded Generics Revenue by Application (2018-2024) & (US$ Million)
Table 90. Asia Branded Generics Revenue by Application (2024-2029) & (US$ Million)
Table 91. Asia Branded Generics Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 92. Asia Branded Generics Revenue by Region (2018-2024) & (US$ Million)
Table 93. Asia Branded Generics Revenue by Region (2024-2029) & (US$ Million)
Table 94. Asia Branded Generics Sales by Region (2018-2024) & (K MT)
Table 95. Asia Branded Generics Sales by Region (2024-2029) & (K MT)
Table 96. Middle East, Africa and Latin America Branded Generics Sales by Type (2018-2024) & (K MT)
Table 97. Middle East, Africa and Latin America Branded Generics Sales by Type (2024-2029) & (K MT)
Table 98. Middle East, Africa and Latin America Branded Generics Revenue by Type (2018-2024) & (US$ Million)
Table 99. Middle East, Africa and Latin America Branded Generics Revenue by Type (2024-2029) & (US$ Million)
Table 100. Middle East, Africa and Latin America Branded Generics Sales by Application (2018-2024) & (K MT)
Table 101. Middle East, Africa and Latin America Branded Generics Sales by Application (2024-2029) & (K MT)
Table 102. Middle East, Africa and Latin America Branded Generics Revenue by Application (2018-2024) & (US$ Million)
Table 103. Middle East, Africa and Latin America Branded Generics Revenue by Application (2024-2029) & (US$ Million)
Table 104. Middle East, Africa and Latin America Branded Generics Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 105. Middle East, Africa and Latin America Branded Generics Revenue by Country (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Branded Generics Revenue by Country (2024-2029) & (US$ Million)
Table 107. Middle East, Africa and Latin America Branded Generics Sales by Country (2018-2024) & (K MT)
Table 108. Middle East, Africa and Latin America Branded Generics Sales by Country (2024-2029) & (K MT)
Table 109. Mylan NV Company Information
Table 110. Mylan NV Description and Major Businesses
Table 111. Mylan NV Branded Generics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 112. Mylan NV Branded Generics Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Mylan NV Recent Developments
Table 114. Novartis AG Company Information
Table 115. Novartis AG Description and Major Businesses
Table 116. Novartis AG Branded Generics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 117. Novartis AG Branded Generics Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Novartis AG Recent Developments
Table 119. Eva Pharmaceutical Industries Company Information
Table 120. Eva Pharmaceutical Industries Description and Major Businesses
Table 121. Eva Pharmaceutical Industries Branded Generics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 122. Eva Pharmaceutical Industries Branded Generics Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Eva Pharmaceutical Industries Recent Developments
Table 124. Pfizer Company Information
Table 125. Pfizer Description and Major Businesses
Table 126. Pfizer Branded Generics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 127. Pfizer Branded Generics Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Pfizer Recent Developments
Table 129. Sun Pharmaceutical Industries Company Information
Table 130. Sun Pharmaceutical Industries Description and Major Businesses
Table 131. Sun Pharmaceutical Industries Branded Generics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 132. Sun Pharmaceutical Industries Branded Generics Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Sun Pharmaceutical Industries Recent Developments
Table 134. Aspen Pharmacare Holding Company Information
Table 135. Aspen Pharmacare Holding Description and Major Businesses
Table 136. Aspen Pharmacare Holding Branded Generics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 137. Aspen Pharmacare Holding Branded Generics Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Aspen Pharmacare Holding Recent Developments
Table 139. Abbott Laboratories Company Information
Table 140. Abbott Laboratories Description and Major Businesses
Table 141. Abbott Laboratories Branded Generics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 142. Abbott Laboratories Branded Generics Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Abbott Laboratories Recent Developments
Table 144. Bausch Health Company Information
Table 145. Bausch Health Description and Major Businesses
Table 146. Bausch Health Branded Generics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 147. Bausch Health Branded Generics Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. Bausch Health Recent Developments
Table 149. Key Raw Materials Lists
Table 150. Raw Materials Key Suppliers Lists
Table 151. Branded Generics Distributors List
Table 152. Branded Generics Customers List
Table 153. Branded Generics Market Trends
Table 154. Branded Generics Market Drivers
Table 155. Branded Generics Market Challenges
Table 156. Branded Generics Market Restraints
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Branded Generics Product Picture
Figure 2. Global Branded Generics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Branded Generics Market Share by Type in 2022 & 2029
Figure 4. Oral Product Picture
Figure 5. Parenteral Product Picture
Figure 6. Topical Product Picture
Figure 7. Other Product Picture
Figure 8. Global Branded Generics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Branded Generics Market Share by Application in 2022 & 2029
Figure 10. Oncology
Figure 11. Cardiovascular Diseases
Figure 12. Diabetes
Figure 13. Neurology
Figure 14. Gastrointestinal Diseases
Figure 15. Others
Figure 16. Branded Generics Report Years Considered
Figure 17. Global Branded Generics Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 18. Global Branded Generics Revenue 2018-2029 (US$ Million)
Figure 19. Global Branded Generics Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 20. Global Branded Generics Revenue Market Share by Region (2018-2029)
Figure 21. Global Branded Generics Sales 2018-2029 ((K MT)
Figure 22. Global Branded Generics Sales Market Share by Region (2018-2029)
Figure 23. US & Canada Branded Generics Sales YoY (2018-2029) & (K MT)
Figure 24. US & Canada Branded Generics Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Europe Branded Generics Sales YoY (2018-2029) & (K MT)
Figure 26. Europe Branded Generics Revenue YoY (2018-2029) & (US$ Million)
Figure 27. China Branded Generics Sales YoY (2018-2029) & (K MT)
Figure 28. China Branded Generics Revenue YoY (2018-2029) & (US$ Million)
Figure 29. Asia (excluding China) Branded Generics Sales YoY (2018-2029) & (K MT)
Figure 30. Asia (excluding China) Branded Generics Revenue YoY (2018-2029) & (US$ Million)
Figure 31. Middle East, Africa and Latin America Branded Generics Sales YoY (2018-2029) & (K MT)
Figure 32. Middle East, Africa and Latin America Branded Generics Revenue YoY (2018-2029) & (US$ Million)
Figure 33. The Branded Generics Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 34. The Top 5 and 10 Largest Manufacturers of Branded Generics in the World: Market Share by Branded Generics Revenue in 2022
Figure 35. Global Branded Generics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 36. Global Branded Generics Sales Market Share by Type (2018-2029)
Figure 37. Global Branded Generics Revenue Market Share by Type (2018-2029)
Figure 38. Global Branded Generics Sales Market Share by Application (2018-2029)
Figure 39. Global Branded Generics Revenue Market Share by Application (2018-2029)
Figure 40. US & Canada Branded Generics Sales Market Share by Type (2018-2029)
Figure 41. US & Canada Branded Generics Revenue Market Share by Type (2018-2029)
Figure 42. US & Canada Branded Generics Sales Market Share by Application (2018-2029)
Figure 43. US & Canada Branded Generics Revenue Market Share by Application (2018-2029)
Figure 44. US & Canada Branded Generics Revenue Share by Country (2018-2029)
Figure 45. US & Canada Branded Generics Sales Share by Country (2018-2029)
Figure 46. U.S. Branded Generics Revenue (2018-2029) & (US$ Million)
Figure 47. Canada Branded Generics Revenue (2018-2029) & (US$ Million)
Figure 48. Europe Branded Generics Sales Market Share by Type (2018-2029)
Figure 49. Europe Branded Generics Revenue Market Share by Type (2018-2029)
Figure 50. Europe Branded Generics Sales Market Share by Application (2018-2029)
Figure 51. Europe Branded Generics Revenue Market Share by Application (2018-2029)
Figure 52. Europe Branded Generics Revenue Share by Country (2018-2029)
Figure 53. Europe Branded Generics Sales Share by Country (2018-2029)
Figure 54. Germany Branded Generics Revenue (2018-2029) & (US$ Million)
Figure 55. France Branded Generics Revenue (2018-2029) & (US$ Million)
Figure 56. U.K. Branded Generics Revenue (2018-2029) & (US$ Million)
Figure 57. Italy Branded Generics Revenue (2018-2029) & (US$ Million)
Figure 58. Russia Branded Generics Revenue (2018-2029) & (US$ Million)
Figure 59. China Branded Generics Sales Market Share by Type (2018-2029)
Figure 60. China Branded Generics Revenue Market Share by Type (2018-2029)
Figure 61. China Branded Generics Sales Market Share by Application (2018-2029)
Figure 62. China Branded Generics Revenue Market Share by Application (2018-2029)
Figure 63. Asia Branded Generics Sales Market Share by Type (2018-2029)
Figure 64. Asia Branded Generics Revenue Market Share by Type (2018-2029)
Figure 65. Asia Branded Generics Sales Market Share by Application (2018-2029)
Figure 66. Asia Branded Generics Revenue Market Share by Application (2018-2029)
Figure 67. Asia Branded Generics Revenue Share by Region (2018-2029)
Figure 68. Asia Branded Generics Sales Share by Region (2018-2029)
Figure 69. Japan Branded Generics Revenue (2018-2029) & (US$ Million)
Figure 70. South Korea Branded Generics Revenue (2018-2029) & (US$ Million)
Figure 71. China Taiwan Branded Generics Revenue (2018-2029) & (US$ Million)
Figure 72. Southeast Asia Branded Generics Revenue (2018-2029) & (US$ Million)
Figure 73. India Branded Generics Revenue (2018-2029) & (US$ Million)
Figure 74. Middle East, Africa and Latin America Branded Generics Sales Market Share by Type (2018-2029)
Figure 75. Middle East, Africa and Latin America Branded Generics Revenue Market Share by Type (2018-2029)
Figure 76. Middle East, Africa and Latin America Branded Generics Sales Market Share by Application (2018-2029)
Figure 77. Middle East, Africa and Latin America Branded Generics Revenue Market Share by Application (2018-2029)
Figure 78. Middle East, Africa and Latin America Branded Generics Revenue Share by Country (2018-2029)
Figure 79. Middle East, Africa and Latin America Branded Generics Sales Share by Country (2018-2029)
Figure 80. Brazil Branded Generics Revenue (2018-2029) & (US$ Million)
Figure 81. Mexico Branded Generics Revenue (2018-2029) & (US$ Million)
Figure 82. Turkey Branded Generics Revenue (2018-2029) & (US$ Million)
Figure 83. Israel Branded Generics Revenue (2018-2029) & (US$ Million)
Figure 84. GCC Countries Branded Generics Revenue (2018-2029) & (US$ Million)
Figure 85. Branded Generics Value Chain
Figure 86. Branded Generics Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries